News
Women’s health start-up Daye expands diagnostic tampon to include STI screening
More than half of Brits admit they have never been for a sexual health check

The UK gynaecological health start-up Daye has expanded its tampon-based vaginal microbiome screening kit to include STI screening.
The tampon-based at-home STI screening kit is hoped to help speed up diagnosis and treatment, particularly among patient groups who are anxious or embarrassed about getting a test.
It uses PCR testing technology to allow women and assigned female at birth (AFAB) individuals to test for chlamydia, gonorrhoea, trichomonas, mycoplasma and ureaplasma from home.
The launch follows clinical trials with 600 patients. The samples will be analysed in a UKAS-accredited lab, following CQC-approved screening methodologies using a PCR-based, CE marked diagnostic assay.
As part of the service, Daye will also provide personalised aftercare, including prescription treatments such as antibiotics and antivirals, and consultations with sexual health nurses, gynaecologists and fertility specialists.
There has been a 24 per cent increase in sexually transmitted infections compared to the previous year, according to the UK Health Security Agency, with women being statistically more at risk than men due to the vaginal physiology.
Despite this, fewer people are getting tested for STIs, with over half of Brits admitting they have never been for a sexual health check.
STIs still carry a lot of stigma, yet are often treatable if caught in time. However, testing is still thought to be embarrassing and uncomfortable.
Low rates of testing mean that many women and AFAB individuals may be unaware they have an STI as 70 per cent of them are asymptomatic.
However, untreated STIs pose risks to long-term health and fertility. Chlamydia and gonorrhoea are two of the leading preventable causes of infertility and ectopic pregnancies.
Mother-to-child transmission of STIs can result in stillbirth, neonatal death, low birth weight and other health complications. Untreated STIs can also lead to chronic pelvic pain and pelvic inflammatory disease.
“Despite living in a world where over a million people get an STI every day, STI testing has chronically low rates post COVID-19, and as a result, many women and AFAB individuals could have an infection unknowingly because they have no symptoms,” said Valentina Milanova, founder of Daye.
“Our STI diagnostic tampon makes STI testing extremely easy, comfortable and discrete.
“We hope our approach will end the ‘STIgma’, revolutionise STI testing and lead to a dramatic uptick in the number of women getting checked, helping them protect their long-term health and fertility.”
According to Daye, the test uses PCR technologies which are able to detect even trace amounts of genetic material from pathogens.
The specificity of PCRs, the company argues, ensures that false-positive results are reduced, providing a more reliable diagnosis and simultaneously detecting multiple pathogens in a single sample.
Dr Michelle Tempest, lecturer in medical law and ethics at Cambridge Medical School and former NHS hospital doctor, said: “Daye’s STI diagnostic tampon is redefining STI testing by allowing women to take control of their sexual health in a non-invasive way in the comfort of their own homes.
“The company’s innovative use of a tampon for screening is supported by various studies that show that tampons are capable of collecting an equivalent or superior sample to a swab.”
Menopause
AI maps how reproductive organs age differently during menopause
Cancer
Ovarian cancer cases rising among younger adults, study finds

Ovarian cancer cases are rising among younger adults in England, with bowel cancer showing a similar pattern, a new study suggests.
Researchers said excess weight is a key contributor, but is unlikely on its own to explain the pattern.
The authors wrote: “These patterns suggest that while similar risk factors across ages are likely, some cancers may have age-specific exposures, susceptibilities, or differences in screening and detection practices.”
They added: “Although overweight and obesity are linked to 10 of the 11 cancers evaluated and account for a substantial proportion of cancer cases, both BMI-attributable and BMI-non-attributable incidence rates have increased, though the latter more slowly, suggesting other contributors.”
The study analysed cancer incidence, meaning new diagnoses, in England between 2001 and 2019 across more than 20 cancer types, comparing adults aged 20 to 49 with those aged 50 and over.
Among younger women, cases of 16 out of 22 cancers increased significantly over the period, while among younger men, 11 out of 21 cancers increased significantly.
In particular, there was a significant rise in 11 cancers with known behavioural risk factors among adults under 50. These were thyroid, multiple myeloma, liver, kidney, gallbladder, bowel, pancreatic, endometrial, mouth, breast and ovarian cancers.
Rates of all 11 also rose significantly among adults aged 50 and over, with the notable exceptions of bowel and ovarian cancer.
Five cancers, endometrial, kidney, pancreatic, multiple myeloma and thyroid cancer, increased significantly faster in younger than in older women, while multiple myeloma increased faster in younger than in older men.
The researchers looked at established risk factors including smoking, alcohol intake, diet, physical inactivity and body mass index, a measure used to assess whether someone is underweight, a healthy weight, overweight or obese.
With the exception of mouth cancer, all 11 cancers were associated with obesity. Six, liver, bowel, mouth, pancreatic, kidney and ovarian, were also linked to smoking.
Four, liver, bowel, mouth and breast, were associated with alcohol intake. Three, bowel, breast and endometrial, were linked to physical inactivity, and one, bowel, was associated with dietary factors.
But apart from excess weight, trends in those risk factors over the past one to two decades were stable or improving among younger adults.
That suggests other factors may also play a part, including reproductive history, early-life or prenatal exposures, and changes in diagnosis and detection.
The study noted that red meat consumption fell among younger adults, while fibre intake remained stable or slightly improved in both sexes between 2009 and 2019, although more than 90 per cent of younger adults were still not eating enough fibre in 2018.
Established behavioural risk factors accounted for a substantial share of cancer cases.
Excess weight was the risk factor associated with most cancers in 2019, ranging from 5 per cent for ovarian cancer to 37 per cent for endometrial cancer.
The researchers said the findings were based on observational data, meaning the study could identify patterns but could not prove cause and effect.
They also noted there were no consistent long-term national data for several risk factors, that the analysis was limited to England rather than the UK, and that cancer remains far more common overall in older adults despite the rise in cases among younger people.
Pregnancy
Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds
Entrepreneur7 days agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Fertility2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health1 week agoLifting weights shows mental health and cognitive benefits in older women, study finds
Mental health2 weeks agoMore research needed to understand link between brain fog and menopause, expert says
Features4 weeks agoCopper coil vs Mirena: Which is right for you?














